Abstract
Methods: Systematic review of cases reported in the medical literature.
Results: 217 published cases were identified, 90 of which fulfilled the study definition and had sufficient individual data on potential risk factors to be included. The 90 patients had a mean age of 40.1 years (range 16–69) and 53% were female. All 90 patients were taking nucleoside reverse transcriptase inhibitors (NRTI) at the time of the episode. Among the 83 patients with details of their antiretroviral therapy (ART) regimen 51 patients were taking stavudine, 29 zidovudine, 27 didanosine, and 25 lamivudine. Around 50% of the patients had abdominal pain, nausea, or vomiting. Hepatic steatosis was consistently reported (53/90) and in 36 (68%) there was histological evidence. The case fatality rate was 48%. Six cases were rechallenged with NRTI and three developed a further LA episode. Using data on the numbers of HIV infected individuals receiving care in the United States, we estimate that the risk of LA could be 2.5 times higher for women than men.
Conclusions: NRTI use and female sex appear to be risk factors for the development of LA. What other factors are involved is still not clear but might include duration of NRTI therapy, specific drug use, and genetic predisposition. A case-control study is needed to better define risk factors for severe LA.
Full Text
The Full Text of this article is available as a PDF (138.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brinkman Kees, Kakuda Thomas N. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy? Curr Opin Infect Dis. 2000 Feb;13(1):5–11. doi: 10.1097/00001432-200002000-00002. [DOI] [PubMed] [Google Scholar]
- Carr A., Morey A., Mallon P., Williams D., Thorburn D. R. Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia. Lancet. 2001 May 5;357(9266):1412–1414. doi: 10.1016/S0140-6736(00)04579-7. [DOI] [PubMed] [Google Scholar]
- Charton-Bain M. C., Flamant M., Aubertin J. M., Belair M. F., Gilquin J., Kazatchkine M., Bruneval P. Acidose lactique et altérations mitochondriales hépatiques au cours d'un traitement par zidovudine. Gastroenterol Clin Biol. 1997;21(12):979–981. [PubMed] [Google Scholar]
- Fortgang I. S., Belitsos P. C., Chaisson R. E., Moore R. D. Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy. Am J Gastroenterol. 1995 Sep;90(9):1433–1436. [PubMed] [Google Scholar]
- Gopinath R., Hutcheon M., Cheema-Dhadli S., Halperin M. Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: biochemical studies. J Am Soc Nephrol. 1992 Dec;3(6):1212–1219. doi: 10.1681/ASN.V361212. [DOI] [PubMed] [Google Scholar]
- Gérard Y., Maulin L., Yazdanpanah Y., De La Tribonnière X., Amiel C., Maurage C. A., Robin S., Sablonnière B., Dhennain C., Mouton Y. Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy. AIDS. 2000 Dec 1;14(17):2723–2730. doi: 10.1097/00002030-200012010-00012. [DOI] [PubMed] [Google Scholar]
- John M., Moore C. B., James I. R., Nolan D., Upton R. P., McKinnon E. J., Mallal S. A. Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS. 2001 Apr 13;15(6):717–723. doi: 10.1097/00002030-200104130-00007. [DOI] [PubMed] [Google Scholar]
- Kakuda T. N. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther. 2000 Jun;22(6):685–708. doi: 10.1016/S0149-2918(00)90004-3. [DOI] [PubMed] [Google Scholar]
- Lonergan J. T., Behling C., Pfander H., Hassanein T. I., Mathews W. C. Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens. Clin Infect Dis. 2000 Jul 26;31(1):162–166. doi: 10.1086/313912. [DOI] [PubMed] [Google Scholar]
- Moyle G. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity. Clin Ther. 2000 Aug;22(8):911–898. doi: 10.1016/S0149-2918(00)80064-8. [DOI] [PubMed] [Google Scholar]
- Sundar K., Suarez M., Banogon P. E., Shapiro J. M. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. Crit Care Med. 1997 Aug;25(8):1425–1430. doi: 10.1097/00003246-199708000-00034. [DOI] [PubMed] [Google Scholar]